REGENXBIO Inc.

NASDAQ: RGNX · Real-Time Price · USD
10.20
0.37 (3.76%)
At close: May 02, 2025, 12:30 PM

REGENXBIO Revenue

REGENXBIO reported an annual revenue of $83.33M, reflecting a -7.66% growth. For the quarter ending December 31, 2024, REGENXBIO generated $21.21M in revenue.
Revenue (ttm)
$83.33M
Revenue Growth
-7.66%
Price / Sales Ratio
4.59
Revenue / Employee
$236.06K
Employees
353
Market Cap
511.19M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.